Show simple item record

dc.contributor.advisorGiraldo Cadavid, Luis Fernando 
dc.creatorMolina Castro, Diego 
dc.date.accessioned2019-01-29T15:42:49Z
dc.date.available2019-01-29T15:42:49Z
dc.date.created2019-01-28
dc.date.issued2019 
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/18952
dc.descriptionEl asma es una patología pulmonar de etiología multifactorial con grandes repercusiones en los sistemas de salud mundial, lo que ha llevado a la creación de programas de atención integral como una estrategia dirigida al mejoramiento de los estándares de atención en salud especialmente en los países en vía de desarrollo, logrando una disminución de los gastos en salud y un mejor tratamiento para los pacientes. Este estudio busca evaluar la efectividad del programa ASMAIRE de la Fundación Neumológica Colombiana, para disminuir el número de exacerbaciones durante el primer año de seguimiento, mediante una cohorte histórica de todos aquellos pacientes incluidos en el programa ASMAIRE adultos, con un diseño del estudio de “antes después” en el cual cada sujeto actuó como su propio control. Se realizó la comparación de las variables previas al ingreso y durante el primer año posterior a este. Se utilizaron densidades de incidencias y modelos uni y multivariados de regresión de Poisson. Se analizaron 715 pacientes encontrando que posterior al ingreso a ASMAIRE se presentó una disminución en las consultas a EPS (RR 0,44 IC95%:0,32;0,61 p=0,0001), urgencias (RR 0,83 IC95%:0,71;0,98 p=0,029) así como la necesidad de hospitalizaciones (RR 0,31 IC95%:0,23;0,42 p=0,0001) e ingreso a UCI (RR 0,07 IC95%:0,03;0,14 p=0,0001). En conclusión el ingreso al programa ASMAIRE, logró disminuir la presencia de exacerbaciones que requirieron consultar a EPS o urgencias así como la necesidad de hospitalizaciones e ingreso a UCI en el primer año de seguimiento.
dc.description.abstractAsthma is a pulmonary disease of multifactorial cause with big burden to all health systems around the world which led to the creation of integral attention programs as an strategy aimed to improving the standards of attention especially in developing countries, reaching a decrease in health expenditures and a improved treatment for patients based on guidelines. This study aims to evaluate the effectivity of the Fundación neumológica's ASMAIRE program to reduce the severe exacerbations during the first year of follow up through a historic cohort of those patient included in the program with a before and after cohort, where every subjects acts as its own control. We did a comparation of the different variables before and after the entry of every patient to the program and one year later. Incidence densities and uni and multivariate Poisson regression models were used. 715 patients were analyzed, finding that after admission to ASMAIRE there was a decrease in EPS consultations (RR 0.44 IC95%: 0.32, 0.61 p = 0.0001), emergencies (RR 0.83 IC95% 0.71, 0.98 p = 0.029) as well as the need for hospitalizations (RR 0.31 IC95%: 0.23, 0.42 p = 0.0001) and admission to the ICU (RR 0.07 IC 95%: 0.03; 0.14 p = 0.0001). In conclusion the admission to the ASMAIRE program, managed to reduce the presence of exacerbations that required consulting EPS or emergencies as well as the need for hospitalizations and admission to the ICU in the first year of follow-up.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectAsma
dc.subjectCalidad de vida
dc.subjectTratamiento
dc.subjectAtención ambulatoria
dc.subjectRecurrencia
dc.subject.ddcEnfermedades 
dc.subject.lembAsma
dc.subject.lembAtención médica ambulatoria
dc.titleEfectividad de un programa de atención integral del paciente con asma sobre la frecuencia de exacerbaciones en una institución de cuarto nivel de la ciudad de Bogotá (Colombia)
dc.typebachelorThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Medicina Interna
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordAsthma
dc.subject.keywordQuality of life
dc.subject.keywordTreatment
dc.subject.keywordAmbulatory follow up
dc.subject.keywordRecurrence
dc.subject.keywordChronic program
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto Completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationPage PM. Global Strategy For Asthma Management and Prevention. Glob Initiat Asthma. 2017;http://ginasthma.org/2017-gina-report-global-strat.
dc.source.bibliographicCitationBaïz N, Annesi-Maesano I. Is the Asthma Epidemic Still Ascending? Clin Chest Med. 2012;33(3):419–29.
dc.source.bibliographicCitationWilliams S a, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009;51:780–5.
dc.source.bibliographicCitationSadatsafavi M, Rousseau R, Chen W, Zhang W, Lynd L, FitzGerald JM. The preventable burden of productivity loss due to suboptimal asthma control: A population -based study. Chest. 2014;145(4):787–93.
dc.source.bibliographicCitationGuénette L, Breton M-C, Grégoire J-P, Jobin M-S, Bolduc Y, Boulet L-P, et al. Effectiveness of an asthma integrated care program on asthma control and adherence to inhaled corticosteroids. J asthma [Internet]. 2015;52(6):638–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25539138
dc.source.bibliographicCitationPeytremannBridevaux I, Arditi C, Gex G, Bridevaux P, Burnand B. Chronic disease management programmes for adults with asthma [Internet]. 2015. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=coch&NEWS=N&AN=00075320-100000000-06409
dc.source.bibliographicCitationMeza D, Puentes UB, Blanc G, García G, Halley D, Duque AT. Evaluación Del Control Niños Y Sus Padres O Cuidadores En Un Programa De Atención Integral Del Asma ( Programa Asmaire Infantil ). 2012;15(4):36–42.
dc.source.bibliographicCitationFontes MJF, Affonso AGA, Calazans GMC, de Andrade CR, Lasmar LMLBF, Nader CMFF, et al. Impact of an asthma management program on hospitalizations and emergency department visits. J Pediatr (Rio J). 2011;87(5):412–8.
dc.source.bibliographicCitationBush A, Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. Proc Am Thorac Soc. 2009;6(8):712–9.
dc.source.bibliographicCitationBy O, Goldberg M, Doughty D, Lawrence K. At Er Ia L At Er L. 2007;(June).
dc.source.bibliographicCitationMedicine R. Front Matter [Internet]. 1991. iii-. Available from: http://www.sciencedirect.com/science/article/pii/B978012525440350002X
dc.source.bibliographicCitationDennis R, Caraballo L, García E, Caballero A, Aristizabal G, Córdoba H, et al. Asthma and other allergic conditions in Colombia: a study in 6 cities. Ann Allergy Asthma Immunol. 2004;93(6):568–74.
dc.source.bibliographicCitationDennis RJ, Caraballo L, García E, Rojas MX, Rondon M a, Pérez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study. BMC Pulm Med [Internet]. BioMed Central Ltd; 2012;12(1):17. Available from: ???12/1471-2466-12-17
dc.source.bibliographicCitationRodríguez L, Rey J, Herrera, AB et al. Prevalencia de síntomas respiratorios indicativos de asma y asociación con contaminación atmosférica en preescolares de Bucaramanga, Colombia. Biomédica. 2010;30:15–22.
dc.source.bibliographicCitationBurke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, et al. Prenatal and Passive Smoke Exposure and Incidence of Asthma and Wheeze: Systematic Review and Meta-analysis. Pediatrics [Internet]. 2012;129(4):735–44. Available from: http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2011-2196
dc.source.bibliographicCitationManuscript A, Pollution T. NIH Public Access. 2013;129(1):3–13.
dc.source.bibliographicCitationAzzola MC. The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy. 2001;606–11.
dc.source.bibliographicCitationNurmatov U, Devereux G, Sheikh A. Asthma and lower airway disease Nutrients and foods for the primary prevention of asthma and allergy : Systematic review and meta-analysis. J Allergy Clin Immunol [Internet]. Elsevier Ltd; 2017;127(3):724–733.e30. Available from: http://dx.doi.org/10.1016/j.jaci.2010.11.001
dc.source.bibliographicCitationSandberg S, Paton JY, Ahola S, Mccann DC, Mcguinness D, Hillary CR, et al. The role of acute and chronic stress in asthma attacks in children. 2000;356:982–7.
dc.source.bibliographicCitationHaahtela T. Review article Asthma and atopy – the price of affluence ? 2004;124–37.
dc.source.bibliographicCitationMaslan J, Mims JW. What is asthma? Pathophysiology, demographics, and health care costs. Otolaryngol Clin North Am [Internet]. Elsevier Inc; 2014;47(1):13–22. Available from: http://dx.doi.org/10.1016/j.otc.2013.09.010
dc.source.bibliographicCitationAccordini S, Corsico G, Braggion M, Gerbase W. The Cost of Persistent Asthma in Europe : An International Population-Based Study in Adults. 2013;93–101.
dc.source.bibliographicCitationSpencer M, Williams AE, Insights A. Cost of asthma in the Asia-Pacific region. 2006;15(98):10–6.
dc.source.bibliographicCitationNetwork GA. The Global Asthma Report Asthma may affect as many as. 2014.
dc.source.bibliographicCitationControl A, Wong A, Sadatsafavi M, Fitzgerald JM, Division RM. ACCEPTED MANUSCRIPT. :1–22.
dc.source.bibliographicCitationVercelli D. Discovering susceptibility genes for asthma and allergy. 2008;8(march).
dc.source.bibliographicCitationYadav M, Stephan S, Bluestone JA. Peripherally inducedTregs – role in immune homeostasis and autoimmunity. 2013;4(August):1–12.
dc.source.bibliographicCitationHoltzman MJ. Review series Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. 2012;122(8):2741–8.
dc.source.bibliographicCitationBonsignore MR, Profita M, Gagliardo R, Riccobono L, Chiappara G, Pace E, et al. Advances in asthma pathophysiology : stepping forward from the Maurizio Vignola experience. 2015;30–9. Available from: http://dx.doi.org/10.1183/09059180.10011114
dc.source.bibliographicCitationHargreave E. hase asthmatic responses an irway inflammation. 1989;7–9.
dc.source.bibliographicCitationMartinez FD, Vercelli D. Asthma. Lancet. 2013;382(9901):1360–72.
dc.source.bibliographicCitationSingh RK, Pharm MS, Tandon R, Dastidar SG, Ray A. A review on leukotrienes and their receptors with reference to asthma. 2013;0903:1–10.
dc.source.bibliographicCitationKrouse JH, Krouse HJ. Asthma diagnosis in otolaryngology practice. Pulmonary function testing. Otolaryngol Clin North Am [Internet]. Elsevier Inc; 2014;47(1):33–7. Available from: http://dx.doi.org/10.1016/j.otc.2013.09.009
dc.source.bibliographicCitationChung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.
dc.source.bibliographicCitationOlin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. Bmj. 2014;349(nov24 8):g5517–g5517.
dc.source.bibliographicCitationWenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in Persistent Asthma with Elevated Eosinophil Levels. N Engl J Med. 2013;368(26):2455–66.
dc.source.bibliographicCitationChinellato I, Piazza M, Sandri M, Peroni D, Cardinale F, Piacentini G, et al. With Asthma. Eur Respir J. 2011;37:1366–70.
dc.source.bibliographicCitationSvensson K, Tattersfield A. Low Dose Inhaled Budesonide and Formoterol in Mild The OPTIMA Randomized Trial.
dc.source.bibliographicCitationJackson DJ, Sykes A, Mallia P. Asthma : Current status and future directions Asthma exacerbations : Origin , effect , and prevention. J Allergy Clin Immunol [Internet]. Elsevier Ltd; 128(6):1165–74. Available from: http://dx.doi.org/10.1016/j.jaci.2011.10.024
dc.source.bibliographicCitationGriswold SK, Nordstrom CR, Clark S, Camargo CA. Asthma Exacerbations in North American Adults * Who Are the “ Frequent Fliers ” in the Emergency. Chest [Internet]. The American College of Chest Physicians; 2005;127(5):1579–86. Available from: http://dx.doi.org/10.1378/chest.127.5.1579
dc.source.bibliographicCitationKoga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med. 2006;100(2):273–8.
dc.source.bibliographicCitationPeters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST, et al. Real-world Evaluation of Asthma Control and Treatment ( REACT ): Findings from a national Web-based survey. 2017;1454–61.
dc.source.bibliographicCitationMiller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: A key predictor of future exacerbations. Respir Med. 2007;101(3):481–9.
dc.source.bibliographicCitationNicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations ofasthma in adults. 1993;307(October).
dc.source.bibliographicCitationJohnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, et al. The September epidemic of asthma exacerbations in children : A search for etiology. 2001;132–8.
dc.source.bibliographicCitationBlack PN, Ch B, Martin RJ, Farrell DJ, Ph D, Nieman RB, et al. The Effect of Telithromycin in Acute Exacerbations of Asthma. 2006;1589–600.
dc.source.bibliographicCitationEnvironmental C, Agency P, Lloyd AC, Denton JE. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant Part B : Health Effects. 2005;
dc.source.bibliographicCitationKattan M, Gergen PJ, Eggleston P, Cynthia M, Mitchell HE, York N. Health care education , delivery , and quality Health effects of indoor nitrogen dioxide and passive smoking on urban asthmatic children. 2017;(2):618–24.
dc.source.bibliographicCitationSuau SJ, DeBlieux PMC. Management of Acute Exacerbation of Asthma and Chronic Obstructive Pulmonary Disease in the Emergency Department. Emerg Med Clin North Am [Internet]. Elsevier Inc; 2016;34(1):15–37. Available from: http://dx.doi.org/10.1016/j.emc.2015.08.002
dc.source.bibliographicCitationSteuten L, Vrijhoef B, Merode FVAN, Wesseling G. Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. 2006;18(6):429–36.
dc.source.bibliographicCitationLemmens KMM, Nieboer AP, Huijsman R. REVIEW A systematic review of integrated use of disease- management interventions in asthma and COPD. Respir Med. Elsevier Ltd; 2009;103(5):670–91.
dc.source.bibliographicCitationGalbreath AD, Smith B, Wood PR, Inscore S, Forkner E, Vazquez M, et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Ann Allergy, Asthma Immunol [Internet]. American College of Allergy, Asthma & Immunology; 2008;101(6):599–607. Available from: http://dx.doi.org/10.1016/S1081-1206(10)60222-0
dc.source.bibliographicCitationJain V V., Allison R, Beck SJ, Jain R, Mills PK, McCurley JW, et al. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD. Respir Med [Internet]. Elsevier Ltd; 2014;108(12):1794–800. Available from: http://dx.doi.org/10.1016/j.rmed.2014.09.010
dc.source.bibliographicCitationWeng H-C. Impacts of a Government-Sponsored Outpatient-Based Disease Management Program for Patients with Asthma: A Preliminary Analysis of National Data from Taiwan. Dis Manag [Internet]. 2005;8(1):48–58. Available from: http://www.liebertonline.com/doi/abs/10.1089/dis.2005.8.48
dc.source.bibliographicCitationNurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–56.
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.type.emcsAnálisis de caso
dc.creator.degreetypeFull time


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 2.5 Colombia

 

Reconocimientos: